1-11 of 11
Alexander J. Ambinder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with TP53 -Mutated Myeloid Neoplasms (TP53-MN) and the Role of Allogenic Blood or Marrow Transplantation (alloBMT)

Sergiu Pasca, Saurav D. Haldar, Alexander J. Ambinder, Jonathan Webster, Tania Jain, William Brian Dalton, Gabrielle T. Prince, Gabriel Ghiaur, Amy E. DeZern, Ivana Gojo, Jonathan Allen Webster, Cory Schulz, Kristin Stokvis, Mark J. Levis, Richard J. Jones, Lukasz P. Gondek
Journal: Blood
Blood (2022) 140 (Supplement 1): 10629–10631.
https://doi.org/10.1182/blood-2022-169148
Published: 2022
Journal Articles

Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Journal: Blood
Blood (2022) 140 (Supplement 1): 4813–4815.
https://doi.org/10.1182/blood-2022-171038
Published: 2022
Journal Articles

Pre- and Post-Transplant Measurable Residual IDH Mutations Are Not Associated with Relapse in Patients with IDH-Mutated AML

Niveditha Ravindra, Laura W. Dillon, Gege Gui, Christopher S. Hourigan, Alexander J. Ambinder
Journal: Blood
Blood (2022) 140 (Supplement 1): 3391–3392.
https://doi.org/10.1182/blood-2022-167374
Published: 2022
Journal Articles

Post-Remission Outcomes in Patients with Acute Myeloid Leukemia (AML) Are Similar between Hypomethylating Agent/Venetoclax Therapy and Intensive Chemotherapy after Accounting for Measurable Residual Disease (MRD) Status

Michael J. Hochman, Alexander J. Ambinder, Lukasz P. Gondek, Amy E. DeZern
Journal: Blood
Blood (2022) 140 (Supplement 1): 3387–3388.
https://doi.org/10.1182/blood-2022-164757
Published: 2022
Journal Articles

Prognostic Impact of Secondary Versus De Novo Ontogeny in Acute Myeloid Leukemia (AML) Is Predominantly Accounted for By the European Leukemianet (ELN) 2022 Risk Classification

Michael J. Hochman, Megan Othus, Robert P. Hasserjian, Alexander J. Ambinder, Andrew M. Brunner, Mary-Elizabeth M. Percival, Christopher S. Hourigan, Ronan Swords, Amy E. DeZern, Elihu H. Estey, Judith E. Karp
Journal: Blood
Blood (2022) 140 (Supplement 1): 1430–1432.
https://doi.org/10.1182/blood-2022-164739
Published: 2022
Journal Articles

Gemtuzumab Ozogamicin for Cytoreduction in Hyperleukocytosis

Matthew Scarlotta, Jonathan Webster, Matthew Newman, Cory Schulz, Kristin Stokvis, Alexander J. Ambinder, Tania Jain, William Brian Dalton, Lukasz P. Gondek, Gabrielle T. Prince, Gabriel Ghiaur, Christopher S. Hourigan, Amy E. DeZern, Ivana Gojo, Jonathan Allen Webster, Mark J. Levis
Journal: Blood
Blood (2022) 140 (Supplement 1): 11747–11748.
https://doi.org/10.1182/blood-2022-160300
Published: 2022
Journal Articles

Incorporating Gemtuzumab into the Treatment of Core Binding Factor Acute Myeloid Leukemia: A Single Center Experience

Natalie S Rosen, Matthew L Smith, Amy E. DeZern, Alexander J. Ambinder
Journal: Blood
Blood (2021) 138 (Supplement 1): 2337.
https://doi.org/10.1182/blood-2021-144443
Published: 2021
Journal Articles

Response Prediction to Isocitrate Dehydrogenase (IDH) Inhibitors in Patients with IDH1 - or IDH2 -Mutated Acute Myeloid Leukemia Using Clinical and Genomic Data

Emma C. Scott, Kamil Kural, Sean Smith, Michael Colgan, Alexander J. Ambinder, Gabriel Ghiaur, Nora Holmes, Dickran Kazandjian, Catherine Lai, Colleen McGuire, Lorraine Pelosof, Svetlana Petrovskaya, V. Ashutosh Rao, Amy Rosenberg, Luis Santana-Quintero, Joseph Wynne, Wenming Xiao, Yong Zhang, R. Angelo de Claro, Richard Pazdur, Julia A. Beaver, Kelly J. Norsworthy
Journal: Blood
Blood (2021) 138 (Supplement 1): 1285.
https://doi.org/10.1182/blood-2021-147099
Published: 2021
Journal Articles

Nonmyeloablative Allogeneic Transplantation in First Remission for Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Outcomes By Receipt of Pre-Transplant Blinatumomab

Jonathan Webster, B. Douglas Smith, Amy E. DeZern, Alexander J. Ambinder, Mark Levis, Margaret M. Showel, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Christopher S. Hourigan, Tania Jain, Douglas E Gladstone, Leo Luznik, Philip H. Imus, Javier Bolanos-Meade, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1846.
https://doi.org/10.1182/blood-2021-153750
Published: 2021
Journal Articles

β-2-Glycoprotein Antibodies Activate the Alternative Pathway of Complement in Antiphospholipid Antibody Syndrome

Andrea C. Baines, MD PhD, Xuan Yuan, MD MSc, Eleni Gavriilaki, MD PhD, Alexander J. Ambinder, MD MPH, Alka Jain, PhD, Neal S. Fedarko, PhD, C. John Sperati, MD MHS, Alison R. Moliterno, MD, Rakhi P. Naik, MD MHS, Michael Streiff, MD, Wei Fu, MS, Michelle Petri, MD MPH, Robert A. Brodsky, MD
Journal: Blood
Blood (2016) 128 (22): 3818.
https://doi.org/10.1182/blood.V128.22.3818.3818
Published: 2016
Journal Articles

Modified Ham test for atypical hemolytic uremic syndrome

Eleni Gavriilaki, Xuan Yuan, Zhaohui Ye, Alexander J. Ambinder, Satish P. Shanbhag, Michael B. Streiff, Thomas S. Kickler, Alison R. Moliterno, C. John Sperati, Robert A. Brodsky
Journal: Blood
Blood (2015) 125 (23): 3637–3646.
https://doi.org/10.1182/blood-2015-02-629683
Published: 2015
Includes: Supplemental data